Q2867196 (Q2867196): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed an Item: Edited by the infer coords bot - inferring coordinates from location) |
||||||||||
| Property / coordinate location | |||||||||||
40°21'55.76"N, 8°39'29.95"W
| |||||||||||
| Property / coordinate location: 40°21'55.76"N, 8°39'29.95"W / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 15:57, 6 July 2021
Project Q2867196 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q2867196 in Portugal |
Statements
492,223.04 Euro
0 references
76.0 percent
0 references
1 April 2020
0 references
31 December 2020
0 references
LIMM THERAPEUTICS, SOCIEDADE ANÓNIMA
0 references
40°21'55.76"N, 8°39'29.95"W
0 references
O projeto apresentado pela LiMM Therapeutics pretende avaliar a possibilidade de desenvolvimento de NRIL01 (reprogramadores neuronais de linfócitos inatos) na presença de SARS-CoV-2, contribuindo desta forma para minimizar as patologias renais como consequência da infeção com este vírus. (Portuguese)
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-02B7-FEDER-069917
0 references